Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

InspireMD (NSPR) EBT (2016 - 2025)

InspireMD filings provide 16 years of EBT readings, the most recent being $27.3 million for Q4 2025.

  • On a quarterly basis, EBT rose 56.64% to $27.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$10.2 million, a 52.51% decrease, with the full-year FY2025 number at -$48.7 million, down 52.52% from a year prior.
  • EBT hit $27.3 million in Q4 2025 for InspireMD, up from -$13.1 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $27.3 million in Q4 2025 to a low of -$13.1 million in Q3 2025.
  • Median EBT over the past 5 years was -$4.7 million (2022), compared with a mean of -$3.6 million.
  • Biggest five-year swings in EBT: tumbled 85.47% in 2021 and later skyrocketed 400.05% in 2024.
  • InspireMD's EBT stood at -$4.1 million in 2021, then dropped by 18.88% to -$4.8 million in 2022, then fell by 20.57% to -$5.8 million in 2023, then skyrocketed by 400.05% to $17.4 million in 2024, then skyrocketed by 56.64% to $27.3 million in 2025.
  • The last three reported values for EBT were $27.3 million (Q4 2025), -$13.1 million (Q3 2025), and -$13.0 million (Q2 2025) per Business Quant data.